Azilsartan medoxomil: all 25 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Bioequivalence Study of Azilsartan Medoxomil 80 mg Tablets (Gedeon Richter Plc., Hungary) and Edarbi® 80 mg Tablets (JSC Nizhpharm, Russia)Not yet recruitingNCT06990204Phase 1
- A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese ParticipantsCompletedNCT02541669Phase 1Results posted
- Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCompletedNCT02517866Phase 4Results posted
- Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionCompletedNCT02480764Phase 3Results posted
- Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionCompletedNCT02203916Phase 3Results posted
- Effect of Azilsartan on Aldosterone in Postmenopausal FemalesCompletedNCT01774591Not applicableResults posted
- Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesTerminatedNCT01496430Phase 3Results posted
- Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCompletedNCT01309828Phase 3Results posted
- A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy AdultsTerminatedNCT01078376Phase 1Results posted
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.CompletedNCT01033071Phase 3Results posted
- Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCompletedNCT00996281Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00847626Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00846365Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCompletedNCT00818883Phase 3Results posted
- Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionCompletedNCT00760214Phase 3Results posted
- An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.CompletedNCT00696436Phase 3Results posted
- A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696384Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00696241Phase 3Results posted
- One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCompletedNCT00695955Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionCompletedNCT00591773Phase 3Results posted
- Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionCompletedNCT00591578Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionCompletedNCT00591266Phase 3Results posted
- Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential HypertensionCompletedNCT00591253Phase 3Results posted
- Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCompletedNCT00362115Phase 2Results posted